NCT03358446

Brief Summary

Evaluation for the range of smallest leg angulation with femoral artery and vein overlap with femoral central catheterization in pediatrics.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
82

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Oct 2017

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 11, 2017

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

November 26, 2017

Completed
4 days until next milestone

First Posted

Study publicly available on registry

November 30, 2017

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 23, 2018

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2018

Completed
Last Updated

July 19, 2018

Status Verified

September 1, 2017

Enrollment Period

5 months

First QC Date

November 26, 2017

Last Update Submit

July 17, 2018

Conditions

Keywords

central catheterizationfemoral vein central catheterizationleg angulation

Outcome Measures

Primary Outcomes (1)

  • A range of angles in which arteries and veins do not overlap

    The optimal range of leg abduction was defined as the range without overlap in A group and the range presenting that the overlap was less-than half of the diameter of femoral vein in S group.

    Intraoperative ( after anesthesia induction)

Study Arms (2)

A group

Based on the presence of non-overlapping range between femoral artery and vein from the initial observation, the patients were divided into following two groups. A group is the patients with non-overlapping range

Other: A group

S group

S group is the patients without non-overlapping range

Other: S group

Interventions

A groupOTHER

The optimal range of leg abduction was defined as the range without overlap in A group and the range presenting that the overlap was less-than half of the diameter of femoral vein in S group. A1 angle defined the point that the femoral vein and artery started non-overlapping interval when increasing the angle of the leg in the A group and the A2 angle is defined the point that the femoral vein and artery ended non-overlapping interval.

A group
S groupOTHER

B1 is the angle at which the overlap starts at the half of the femoral vein radius when increasing the angle of the leg in the S group, B2 is the angle at which overlap starts at half or more of the femoral vein radius again. In the range of B1 and B2 angles, they are overlapped by half or less of the femoral vein radius.

S group

Eligibility Criteria

AgeUp to 36 Months
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

Patients scheduled for elective surgery.

You may qualify if:

  • Pediatric patients younger than 3 years
  • ASA class 1-3
  • Patients scheduled for elective surgery.
  • If the patient's guardian can understand and write the contents of the agreement.

You may not qualify if:

  • A patient with previous history of dislocation of the hip.
  • Hip joints with limited hip movement.
  • A patient with vascular malformation of the femoral vein
  • Emergency surgery
  • Hemodynamic unstable patient
  • If the patient's guardian cannot understand and write the contents of the agreement.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Samsung Medical Center, Sungkyunkwan University, School of Medicine

Seoul, 135-710, South Korea

Location

MeSH Terms

Conditions

Emergencies

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • jonghwan lee, MD, PhD

    Samsung Medical Center, Sungkyunkwan University School of Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 26, 2017

First Posted

November 30, 2017

Study Start

October 11, 2017

Primary Completion

March 23, 2018

Study Completion

May 31, 2018

Last Updated

July 19, 2018

Record last verified: 2017-09

Locations